{
    "nctId": "NCT04042298",
    "briefTitle": "Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy",
    "officialTitle": "Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy",
    "overallStatus": "UNKNOWN",
    "conditions": "Gastrointestinal Cancer, Head and Neck Cancer, Breast Cancer, Chemotherapy Effect, 5-Fluorouracil Toxicity",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 106,
    "primaryOutcomeMeasure": "Cutaneous (skin) blood flow (%) following administration of vasoactive substances",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Give voluntary consent to participate in the study\n* (Group 1) Current cancer treatment includes 5-FU\n* (Group 2) Current cancer treatment does not include 5-FU\n* (Group 3) Cancer survivor previously treated with 5-FU but has not received cancer treatment in the year proceeding enrollment.\n* (Group 4) Age, sex, and health matched (excluding cancer) control for Group 1\n\nExclusion Criteria:\n\n* (Groups 1, 2, and 4) Have received cancer treatment outside of the past year\n* Not met above criteria\n* Pregnant, breastfeeding, or planning to become pregnant\n* Unable to provide informed consent",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}